WFNS Innovation Committee Forms Landmark Partnership with Time Medical International Ventures

WFNS Innovation Committee Forms Landmark Partnership with Time Medical International Ventures

WFNS Innovation Committee Forms Landmark Partnership with Time Medical International Ventures​

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced a landmark collaboration with Time Medical International Ventures (India) Pvt. Ltd, a wholly owned subsidiary of Fischer Medical Ventures Limited. This partnership marks a significant milestone in advancing global neurosurgical care by integrating advanced medical technology with global neurosurgical leadership.

The collaboration represents a historic first for the WFNS Innovation & Technology Committee, as the organization formally welcomes an industry partner into its innovation ecosystem. The partnership aims to strengthen global neurosurgical innovation through advanced medical imaging and technology partnerships.

According to the announcement, the partnership will focus on advancing global neurosurgical innovation through cutting-edge neurosurgical technologies, advanced medical imaging, and global training and knowledge-sharing initiatives, with the goal of improving patient outcomes worldwide. Both organizations are committed to setting a new benchmark for ethical, innovation-led partnerships in neurosurgical care.

Time Medical International Ventures Pvt. Ltd. has been recognized for its contributions in advanced medical imaging and neurosurgical technologies. Its expertise includes single-room intraoperative MRI operation suites, Exoscope and visualisation technologies, and specialized MRI solutions for brain aneurysm and ICAD screening. This association is anticipated to build a robust platform for innovation-driven advancements in neurosurgery and neuroimaging.

Commenting on the partnership, Prof. Dr. Iype Cherian, Chairperson of the WFNS Innovation & Technology Committee, stated that the committee is opening its doors to the private sector for the first time. He added that the collaboration will help champion the development and global dissemination of cutting-edge neurosurgical solutions and support training and technology transfer initiatives in emerging markets.

Svetlana Rao, Director of Time Medical International Ventures (India) Pvt. Ltd., expressed that the company is honored to be welcomed as an Industry Partner. She emphasized that, as a wholly owned subsidiary of Fischer Medical Ventures Limited, Time Medical India remains committed to supporting transformative healthcare solutions that improve accessibility, precision, and patient outcomes across diverse healthcare systems.

The WFNS Innovation & Technology Committee expressed confidence that this partnership will set a new standard for the role of industry within global neurosurgical governance. Both organizations affirmed their collective goal to shape the future of neurosurgery through shared vision, innovation, and an enduring commitment to improving patient outcomes worldwide.

About Time Medical International Ventures (India) Private Limited​

Time Medical International Ventures (India) Private Limited is a global leader in advanced medical imaging solutions and a wholly owned subsidiary of Fischer Medical Ventures Limited. Headquartered in Chennai, Time Medical India specializes in the design and manufacture of high-performance, cost-effective MRI systems that aim to democratize access to advanced diagnostic imaging across emerging and developed markets.

FISCHER Stock Price Movement​

As of 1:12 PM, shares of Fischer Medical Ventures Limited are shedding 0.22% in live trading, currently at ₹35.57. The stock sees significant activity today, posting a volume of 707,697 shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top